THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

ALPS ADVISORS INC's Holding History (CIK: 0001376113)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 41,608 Value ($000) $778 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 24,214 Value ($000) $354 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 27,007 Value ($000) $298 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 36,079 Value ($000) $322 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 39,759 Value ($000) $374 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 37,436 Value ($000) $302 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 37,944 Value ($000) $322 Avg Close $9.03 Range $8.13 - $10.44
Q3 2018
Shares 97,513 Value ($000) $3,186 Avg Close $27.25 Range $22.26 - $32.79
Q2 2018
Shares 79,607 Value ($000) $1,805 Avg Close $23.74 Range $21.27 - $26.00
Q1 2018
Shares 72,564 Value ($000) $1,760 Avg Close $27.46 Range $22.90 - $30.29
Q4 2017
Shares 59,951 Value ($000) $1,672 Avg Close $29.59 Range $25.20 - $35.90
Q3 2017
Shares 53,013 Value ($000) $1,815 Avg Close $32.70 Range $23.15 - $42.61
Q2 2017
Shares 48,069 Value ($000) $1,915 Avg Close $38.45 Range $34.85 - $43.44
Q1 2015
Shares 15,967 Value ($000) $277 Avg Close $18.33 Range $14.59 - $22.00